Treatment Progress in Diminished Ovarian Reserve: Western and Chinese Medicine.
10.1007/s11655-021-3353-2
- Author:
Qiao-Li ZHANG
1
;
Ya-Ling LEI
2
;
Yan DENG
3
;
Rui-Lin MA
3
;
Xue-Song DING
3
;
Wei XUE
3
;
Ai-Jun SUN
4
Author Information
1. Department of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, 100026, China.
2. Department of Encephalopathy, Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, 710000, China.
3. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
4. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China. saj_pumch@sina.com.
- Publication Type:Review
- Keywords:
Chinese medicine;
Western medicine;
diminished ovarian reserve;
treatment
- MeSH:
Female;
Humans;
Medicine, Chinese Traditional;
Ovarian Reserve;
Quality of Life;
Oocytes;
Treatment Outcome;
Infertility, Female/therapy*
- From:
Chinese journal of integrative medicine
2023;29(4):361-367
- CountryChina
- Language:English
-
Abstract:
Diminished ovarian reserve (DOR), generally defined as a decreased number or quality of oocytes, has a significant impact on quality of life and fertility in women. In recent years, the incidence of DOR has been increasing and the ages of patients are younger. The search for an effective DOR treatment has emerged as one of the preeminent research topics in reproductive health. An effective DOR therapy would improve ovarian function, fertility, and quality of life in patients. In this review we evaluated DOR treatment progress both in Western medicine and Chinese medicine, and elucidated the characteristics of each treatment.
